Author:
Mutyoba Joan Nankya,Wandera Claude,Ejalu David,Seremba Emmanuel,Beyagira Rachel,Amandua Jacinto,Mugagga Kaggwa,Kambugu Andrew,Muganzi Alex,Easterbrook Philippa,Ocama Ponsiano
Abstract
Abstract
Background
Despite facing a dual burden of HBV and HIV, Africa lacks experience in offering integrated care for HIV and HBV. To contextualize individual and group-level feasibility and acceptability of an integrated HIV/HBV care model, we explored perspectives of health care providers and care recipients on feasibility and acceptability of integration.
Methods
In two regional hospitals of West Nile region, we performed a demonstration project to assess feasibility and acceptability of merging the care of HBV-monoinfected patients with existing HIV care system. Using interviews with health care providers as key informants, and 6 focus groups discussions with 3 groups of patients, we explored feasibility [(i)whether integration is perceived to fit within the existing healthcare infrastructure, (ii) perceived ease of implementation of HIV/HBV integrated care, and (iii) perceived sustainability of integration] and acceptability [whether the HIV/HBV care model is perceived as (i) suitable, (ii) satisfying and attractive (iii) there is perceived demand, need and intention to recommend its use]. We audio-recorded the interviews and data was analysed using framework analysis.
Results
The following themes emerged from the data (i) integrating HBV into HIV care is perceived to be feasible, fit and beneficial, after making requisite adjustments (ii) integration is acceptable due to the need for both free treatment and anticipated collaboration between HIV and HBV clients in terms of peer-support (iii) there are concerns about the likely rise in stigma and the lack of community awareness about integrated care.
Conclusion
The integrated HIV/HBV care model is feasible and acceptable among both providers and recipients. Necessary adjustments to the existing care system, including training, for community sensitization on the reasons and significance of integration are required.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55.
2. Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World J Clin cases. 2018;6(13):589.
3. Organization WH. Prevention and control of viral hepatitis infection: framework for global action. World Health Organization; 2012. https://www.who.int/publications/i/item/prevention-and-control-of-viral-hepatitis-infection-framework-for-global-action.
4. WHO Africa. Factsheet on Uganda population HIV Impact Assessment World Health Organization. 2017. Available from: https://www.afro.who.int/publications/fact-sheet-uganda-population-hiv-impact-assessment.
5. Chiesa A, Ochola E, Oreni L, Vassalini P, Rizzardini G, Galli M. Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon? PLoS ONE. 2020;15(11):e0242278.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献